Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Leiomyoma × Clomiphene × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Polycystic Ovary Syndrome 27 Infertility 10 Anovulation 6 Rare Diseases 1 Prolactinoma 1 Primary Ovarian Insufficiency 1 Motor Activity 1 Leiomyoma 1 Hypogonadism 1 Hyperinsulinism 1 Hyperandrogenism 1 Endocrine System Diseases 1 Dry Eye Syndromes 1

Interventions

Uterine Myomectomy 9 telapristone acetate 8 Uterine Artery Embolization 8 asoprisnil 7 ulipristal acetate 6 estradiol, norethindrone drug combination 6 elagolix 6 Mifepristone 5 Estradiol 5 vilaprisan 4 ulipristal 4 relugolix 4 linzagolix 4 Norethindrone Acetate 4 Tranexamic Acid 3 Sodium Chloride 3 Leuprolide 3 Hysterectomy 3 Gonadotropin-Releasing Hormone 3 Embolization, Therapeutic 3 cetrorelix 2 Saline Solution 2 Radiofrequency Ablation 2 Progestins 2 Letrozole 2 Goserelin 2 Endometrial Ablation Techniques 2 Anesthesia, General 2 pirfenidone 1 epigallocatechin gallate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04177693 2023-06-05

Pharmacokinetics and Hepatic Safety of EGCG

Yale University

Phase 1 Completed

39 enrolled 18 charts

Leiomyoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡